Uniphar (LSE:UPR) Shares Outstanding (EOP): 260 Mil (As of Dec. 2025)


LSE:UPR Uniphar PLC LSE:UPR
84 GF Score
Price £3.93
GF Value £3.13
Valuation Modestly Overvalued
! 9 Warning Signs
View Full Analysis

What is Uniphar Shares Outstanding (EOP)?

Uniphar LSE:UPR 84 Shares Outstanding (EOP) is 260 Mil as of Dec. 2025. GuruFocus rates LSE:UPR with a GF Score™ of 84/100 and a GF Value™ of £3.13 (Modestly Overvalued). The stock has 9 warning signs investors should review.

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. Uniphar's shares outstanding for the quarter that ended in Dec. 2025 was 260 Mil.

Uniphar's quarterly shares outstanding stayed the same from Jun. 2025 (260 Mil) to Dec. 2025 (260 Mil).

Uniphar's annual shares outstanding declined from Dec. 2024 (273 Mil) to Dec. 2025 (260 Mil). It means Uniphar bought back shares from Dec. 2024 to Dec. 2025 .


Uniphar  (LSE:UPR) Shares Outstanding (EOP) Explanation

A company may buy back shares or issue shares in any fiscal period. If a company buys back shares, we should observe that the total number of shares decline. If the company issues new shares, the number of shares outstanding increases.

Usually the presence of treasury shares and a history of buyback are good indicators that company has competitive advantage. But studies have shown that companies usually buy back at wrong time. Buying back shares below its intrinsic value increases value for remaining shareholders. Buying back overvalued shares destroys value for existing shareholders.


Be Aware

Warren Buffett looks for consistency and upward long term trend. Because of share repurchase it is possible for net earnings trend to differ from EPS trend. He preferred net income over EPS. The companies with durable competitive advantage companies report higher % net earnings to total revenues.

Important: If a company is showing net earnings history greater than 20% on total revenues, it is probably benefiting from a long term competitive advantage.

If net earnings is less than 10%, likely to be in a highly competitive business.


Uniphar Shares Outstanding (EOP) Related Terms


Uniphar Shares Outstanding (EOP) Historical Data

* Premium members only.

The historical data trend for Uniphar's Shares Outstanding (EOP) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Uniphar Shares Outstanding (EOP) Chart

Uniphar Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Shares Outstanding (EOP)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 273.02 273.02 273.02 273.02 259.57

Uniphar Semi-Annual Data
Dec16 Dec17 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Shares Outstanding (EOP) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 273.02 273.02 273.02 259.57 259.57

LSE:UPR vs MCK, CAH, COR: Shares Outstanding (EOP) Comparison

For the Medical Distribution subindustry, Uniphar's Shares Outstanding (EOP), along with its competitors' market caps and Shares Outstanding (EOP) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Uniphar Shares Outstanding (EOP) vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Uniphar's Shares Outstanding (EOP) distribution charts can be found below:

* The bar in red indicates where Uniphar's Shares Outstanding (EOP) falls into.


LSE:UPR
84GF Score
Uniphar PLC LSE:UPR
Shares Outstanding (EOP) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Uniphar Shares Outstanding (EOP) Calculation

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. They have voting rights and represent ownership in the corporation by the person that holds the shares. They should be distinguished from treasury shares, which are shares held by the corporation itself, having no exercisable rights.

Shares outstanding can be calculated as either basic or fully diluted. The fully diluted shares outstanding count includes diluting securities, such as options, warrants or convertibles.

Please note: GuruFocus named Shares Outstanding (EOP) is the shares for that end of period. It is usually used to calculate balance sheet related items, such as Book Value per Share, etc. While Shares Outstanding (Diluted Average) and Shares Outstanding (Basic Average) are the weighted average shares over a period of time (a year, a quarter, or so). They are usually used to calculate income statement or cashflow statement related items, such as Earnings per Share (Diluted), etc.

What does a Shares Outstanding (EOP) of 260 Mil mean?
Uniphar (LSE:UPR) has a Shares Outstanding (EOP) of 260 Mil as of Dec. 2025. The total shares a company has outstanding, at period-end. View historical data on Uniphar and its competitors.
Is Uniphar's Shares Outstanding (EOP) too high?
Uniphar's current Shares Outstanding (EOP) is 260 Mil. Overall, Uniphar has a GF Score™ of 84/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Uniphar's Shares Outstanding (EOP) compare to MCK and CAH?
Uniphar's Shares Outstanding (EOP) of 260 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Shares Outstanding (EOP) for a Medical Distribution company?
A good Shares Outstanding (EOP) depends on the Medical Distribution industry context. However, Shares Outstanding (EOP) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Shares Outstanding (EOP) mean?
A high Shares Outstanding (EOP) can signal that a stock is expensive relative to its fundamentals. The total shares a company has outstanding, at period-end. View historical data on Uniphar and its competitors. Uniphar's current Shares Outstanding (EOP) is 260 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Uniphar stock overvalued right now?
Based on GuruFocus' analysis, Uniphar (LSE:UPR) is currently considered Modestly Overvalued. The stock's GF Value™ is £3.13, compared to a current price of £3.93 — trading 25.6% above its estimated fair value. The current Shares Outstanding (EOP) is 260 Mil. Uniphar's overall GF Score™ is 84/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Shares Outstanding (EOP) calculated?
Shares Outstanding (EOP) is calculated from a company's financial statements. For Uniphar (LSE:UPR), the current Shares Outstanding (EOP) is 260 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Uniphar (LSE:UPR) Overvalued in 2026?

Based on GuruFocus' analysis, Uniphar stock appears to be overvalued. The current stock price of £3.93 is trading 25.6% above its estimated GF Value™ of £3.13. GuruFocus considers Uniphar to be Modestly Overvalued.

Key valuation signals for LSE:UPR:

  • Shares Outstanding (EOP): 260 Mil
  • GF Value™: £3.13 vs. price of £3.93 (25.6% above fair value)
  • GF Score™: 84/100 with 9 warning signs

No single metric tells the full story. See the LSE:UPR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Uniphar Business Description

Other Exchanges UPR:Ireland0NR:Germany
Address 4045 Kingswood Road, Citywest Business Park, Dublin, IRL, D24 V06K
Uniphar PLC is a service provider within the pharmaceutical and healthcare sector. The company is an international diversified healthcare services business servicing the requirements of multinational pharmaceutical and medical technology manufacturers across three divisions - Uniphar Pharma, Uniphar Medtech and Uniphar Supply Chain & Retail. Uniphar Pharma enables pharma and biotech companies to bring medicines to markets globally and provide healthcare professionals with access to medicines that can't be sourced through traditional channels. Uniphar Medtech is a Pan-European medical device distributor and solutions partner. Uniphar Supply Chain & Retail is the pharmaceutical wholesaler in Ireland offering of retail pharmacies.
84GF Score

Get the complete analysis for LSE:UPR

Shares Outstanding (EOP) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

£3.93
Price
£3.13
GF Value